tocacco plant Native American Tobaccoo flower, leaves, and buds

tocacco Tobacco is an annual or bi-annual growing 1-3 meters tall with large sticky leaves that contain nicotine. Native to the Americas, tobacco has a long history of use as a shamanic inebriant and stimulant. It is extremely popular and well-known for its addictive potential.

tocacco nicotina Nicotiana tabacum

tocacco Nicotiana rustica leaves. Nicotiana rustica leaves have a nicotine content as high as 9%, whereas Nicotiana tabacum (common tobacco) leaves contain about 1 to 3%

tocacco cigar A cigar is a tightly rolled bundle of dried and fermented tobacco which is ignited so that its smoke may be drawn into the mouth. Cigar tobacco is grown in significant quantities in Brazil, Cameroon, Cuba, Dominican Republic, Honduras, Indonesia, Mexico, Nicaragua, Sumatra, Philippines, and the Eastern United States.

tocacco Tobacco is an agricultural product processed from the fresh leaves of plants in the genus Nicotiana. It can be consumed, used as an organic pesticide, and in the form of nicotine tartrate it is used in some medicines. In consumption it may be in the form of cigarettes smoking, snuffing, chewing, dipping tobacco, or snus.

tocacco
Tobacco-Facts ads

Action against Philip Morris USA to prevent Promoting Lights Cigarettes

Washington, D.C. - The U.S. Food and Drug Administration today took strong, quick action against Philip Morris USA to prevent the tobacco company from evading the new ban on promoting cigarettes as “light,” “mild” or “low-tar” that takes effect on June 22. The ban on these deceptive terms is a key provision of the new federal law giving the FDA authority to regulate tobacco products. It seeks to end a decades-long tobacco industry fraud that has falsely promoted some cigarette brands as less harmful and sought to discourage smokers from quitting.

According to a letter the FDA sent to Philip Morris today, the company has attached “onserts” to its Marlboro Lights packs that state, “Your Marlboro Lights pack is changing. But your cigarette stays the same. In the future, ask for ‘Marlboro in the gold pack.’”

The FDA letter states, “FDA is concerned that the statements included in the onserts attached to the individual packs of Marlboro Lights may perpetuate the mistaken beliefs associated with your “light” cigarettes when marketed as Marlboro in the gold pack. By stating that only the packaging is changing, but the cigarettes will stay the same, the onsert suggests that Marlboro in the gold pack will have the same characteristics as Marlboro Lights, including any mistaken attributes associated with the “light” cigarettes.”

The FDA is correctly demanding that the company turn over all market research it has conducted or possesses on how consumers react to changes in the Marlboro Lights package, including their perceptions about the new gold packs. This will give the FDA the information it needs to take additional enforcement action if Philip Morris does not pull the onserts. Under the law, tobacco companies may not use any marketing that explicitly or implicitly suggests a cigarette brand is less harmful than others.

In addition to the onserts, Philip Morris and other tobacco companies are using lighter-colored packaging for light brands and switched to terms such as “gold” and “silver” to replace “light” and “ultra-light” to circumvent the ban.

We applaud the FDA’s action as a crucial first step toward keeping the tobacco industry from continuing the “light” and “low-tar” deception. We call on Philip Morris to go beyond the actions called for by the FDA and immediately stop using these onserts. In fact, all tobacco companies and retailers should cease any activity that communicates to consumers that “light” or “low-tar” brands are still available. Any activity that misleads consumers into believing that certain cigarettes are safer and discourages smokers from quitting is harmful to public health.

Letter from the FDA to Philip Morris

Food and Drug Administration
Center for Tobacco Products
9200 Corporate Boulevard
Rockville MD 20850-3229

June 17, 2010

Denise F. Keane
Executive Vice President
and General Counsel
Altria Group, Inc.
6601 W. Broad Street
Richmond, Virginia 23230

Dear Ms. Keane:

The Food and Drug Administration (FDA) is aware that Philip Morris USA, Inc., is marketing its Marlboro Lights cigarettes with an onsert, which we understand is currently attached to individual packs of Marlboro Lights cigarettes sold to consumers. The onserts include the following statements:

* YOUR MARLBORO LIGHTS PACK IS CHANGING.
* BUT YOUR CIGARETTE STAYS THE SAME.
* IN THE FUTURE, ASK FOR ‘MARLBORO IN THE GOLD PACK.’

Under section 911 of the Federal Food, Drug, and Cosmetic Act (FFDCA or the Act) (21 U.S.C. § 387k), as amended by the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) (Public Law 111-31), no person may introduce or deliver for introduction into interstate commerce any modified risk tobacco product without an FDA order in effect under section 911(g) of the FFDCA (21 U.S.C. § 387k(g)). A “modified risk tobacco product” includes, among other things, a tobacco product where the product’s label, labeling or advertising uses the descriptors “light,” “mild,” or “low,” or similar descriptors. FFDCA § 911(b)(2) (21 U.S.C. § 387k(b)(2)).

The provision regarding use of “light,” “mild,” or “low,” or similar descriptors takes effect on June 22, 2010, with respect to the manufacture of tobacco products for sale or distribution. Id. at § 911(b)(3) (21 U.S.C. § 387k(b)(3)). Manufacturers, however, may no longer introduce any such products into domestic commerce on or after July 22, 2010, irrespective of the date of manufacture. Id. After the effective date, the introduction of any tobacco product using “light,” “mild,” “low,” or similar descriptors into interstate commerce, without an FDA order in effect under section 911(g) (21 U.S.C. § 387k(g)), is a prohibited act. Id. at §§ 301(a) & (pp) (21 U.S.C. §§ 331(a) & (pp)). Such products also are adulterated under section 902(8) of the FFDCA (21 U.S.C. § 387b(8)).

In enacting the Tobacco Control Act, Congress found that “many smokers mistakenly believe that ‘low tar’ and ‘light’ cigarettes cause fewer health problems than other cigarettes.” Tobacco Control Act § 2(38). FDA is concerned that the statements included in the onserts attached to the individual packs of Marlboro Lights may perpetuate the mistaken beliefs associated with your “light” cigarettes when marketed as Marlboro in the gold pack. By stating that only the packaging is changing, but the cigarettes will stay the same, the onsert suggests that Marlboro in the gold pack will have the same characteristics as Marlboro Lights, including any mistaken attributes associated with the “light” cigarettes.

Although the onsert includes some disclaimer language, Congress found that disclaimers have been ineffective in eliminating mistaken beliefs regarding “low tar” and “light” cigarettes. Tobacco Control Act §§ 2(41) and (42). We are concerned that the disclaimers in your onsert would likewise be ineffective in mitigating any potential mistaken beliefs that may be perpetuated by your onsert.

In light of these concerns, FDA requests and therefore you are to submit, in accordance with section 904(b) of the FFDCA (21 U.S.C. § 387d(b)), the following documents in your possession, custody, or control, including documents in the possession of any agents of Philip Morris:

1. All documents referring or relating to any onsert or other written materials for dissemination to consumers concerning the marketing or sale of Marlboro in the gold pack or any change in the packaging of Marlboro Lights, including all materials about market strategies, themes, concepts, creative recommendations, and dissemination strategies or plans.
2. All documents referring or relating to marketing research, regardless of whether qualitative, empirical, or otherwise, concerning Marlboro in the gold pack, including the onserts provided with the Marlboro Lights packs. Such documents include, but are not limited to, any documents relating to:

a. consumers’ concerns, beliefs, perceptions, understandings, thoughts or impressions about:

i. the marketing or sale of Marlboro in the gold pack;
ii. any onsert included on or with Marlboro Light packages;
iii. any other materials for dissemination to consumers concerning the marketing of Marlboro in the gold pack;
iv. any correlations between the color or word “gold” and taste, the yields of tar, nicotine, or other tobacco constituents, or health risk or product harm;

b. messages, communications, or beliefs intended to be conveyed about the marketing or sale of Marlboro in the gold pack or any onserts included on or with Marlboro Light packages or other written materials for dissemination to consumers concerning the marketing or sale of Marlboro in the gold pack.

3. All documents referring or relating to any written materials disseminated to any distributor or retailer concerning messages or communications these distributors or retailers should convey to consumers concerning the marketing or sale of Marlboro in the gold pack or any onsert included on or with Marlboro Lights packages.

For purposes of these requests, the word “documents” shall include all non-identical written, typed, printed, transcribed, taped, recorded, filmed, computer-stored, or graphic materials, including but not limited to correspondence, memoranda, reports, electronic communications and any attachments thereto, charts, tabulations, images, or graphs.

All documents requested above are to be received by the Center for Tobacco Products (CTP) no later than July 30, 2010. If you anticipate difficulties with this document production, please contact CTP within 15 days of receipt of this letter so that we may assist you in resolving any technical difficulties you may have and facilitate compliance with the above timeline.

The failure to provide information requested by FDA in accordance with section 904(b) of the Act is a violation of the Act and subject to regulatory and enforcement action by FDA. FFDCA §§ 301(q)(1)(B) & 903(a)(10)(A) (21 U.S.C. §§ 331(q)(1)(B) & 387c(a)(10)(A)).

Consistent with applicable statutes and regulations, the confidentiality of trade secret and confidential commercial information submitted to FDA pursuant to this request will be preserved.

We encourage you to submit your response in an electronic format on CD-ROM or DVD. Please see the enclosed document for guidance in preparing your electronic submission to FDA.

Your submission should be prominently identified with the label [FDA 06-2010 – Onsert Request] and sent to the following address:

Center for Tobacco Products
Food and Drug Administration
Attn: Document Control Center
9200 Corporate Boulevard
Rockville, Maryland 20850

We look forward to your prompt response. If you have questions regarding this document request, please contact:
Ann Simoneau, J.D.
Acting Director
Office of Compliance
Center for Tobacco Products
Food and Drug Administration
301-796-9295

Emil Wang, J.D.
Supervisory Regulatory Counsel
Office of Compliance
Center for Tobacco Products
Food and Drug Administration
301-796-9244

Sincerely,
Lawrence R. Deyton, M.S.P.H., M.D.
Director, Center for Tobacco Products

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • Technorati
  • StumbleUpon
  • Google Bookmarks
  • MySpace
  • MyShare
  • RSS
  • Twitter
  • Simpy
  • Sphinn
  • Yahoo! Buzz
  • Blogosphere News
  • Mixx
  • Reddit
  • Propeller
  • MisterWong
  • LinkedIn

Related posts:

  1. Philip Morris packaging now in FDA compliance Pale-blue “FDA Compliant” signs with big, red check marks are...
  2. Philip Morris International 1Q profit rises Higher selling prices helped boost cigarette maker Philip Morris International...
  3. Coded to Obey Law, Marlboro Lights Become Marlboro Gold When it comes to new rules for marketing so-called light...
  4. Philip Morris to challenge ban on display of tobacco products A County Donegal shopkeeper will join forces with cigarette manufacturer...
  5. Philip Morris Pushes Smokeless Tobacco giant Philip Morris USA Inc. is urging the Food...
  6. Philip Morris opens new Subic warehouse THE LOCAL arm of cigarette maker Philip Morris International expects...
  7. Rivals pursue same goal: Reynolds American, Philip Morris prod FDA Pursuing a reduced-risk niche for smokeless-tobacco products has put archrivals...
  8. Philip Morris International 3Q profit falls RICHMOND, Va. — Cigarette maker Philip Morris International Inc., which...
  9. Philip Morris International Inc. Reports 2009 Results Philip Morris International Inc. (PMI) is the leading international tobacco...

Tobacco-Facts ads
discount cigarettes online

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word